Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy-Reference-Cited by-同舟云学术

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy

Published:2008-05-27 Issue:4 Volume:123 Page:933-941
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Flesch-Janys Dieter,Slanger Tracy,Mutschelknauss Elke,Kropp Silke,Obi Nadia,Vettorazzi Eik,Braendle Wilhelm,Bastert Gunter,Hentschel Stefan,Berger Jürgen,Chang-Claude Jenny

Funder

Deutsche Krebshilfe e.V

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer;Collaborative group on hormonal factors in breast cancer;Lancet,1997

2. Breast cancer and hormone-replacement therapy in the Million Women Study;Beral;Lancet,2003

3. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk;Lee;Br J Cancer.,2005

4. Postmenopausal estrogen and progestin use in relation to breast cancer risk;Newcomb;Cancer Epidemiol Biomarkers Prev,2002

5. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin;Ross;J Natl Cancer Inst,2000

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social relationships and their impact on health‐related quality of life in a long‐term breast cancer survivor cohort;Cancer;2024-05-17

2. Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?;Endocrinology;2024-03-29

3. Circulating oxysterols and prognosis among women with a breast cancer diagnosis: results from the MARIE patient cohort;BMC Medicine;2023-11-14

4. Does breast cancer modify the long‐term relationship between lifestyle behaviors and mortality? A prospective analysis of breast cancer survivors and population‐based controls;Cancer;2023-11-11